Pre-IPO Investor Conference Call
June 20, 2017
On June 20, 2017, Imagion Biosystems President and CEO Bob Proulx provided an update and briefing on the pending Imagion Biosystems initial public offering on
Tag: MagSense
HER-2 Positive Tumor Detection at Tech Connect World Innovation Conference
June 2, 2017
This year’s Tech Connect World Innovation Conference featured the poster “Superparamagnetic relaxometry (SPMR) for sensitive detection of HER-2 positive tumors in mice” presented by Imagion
Detecting Small Tumors
March 10, 2017
Cancerous tumors start small and grow larger over time, adding defensive mechanisms that make them resistant to treatments and more deadly. So, to find cancers